| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $748K | +0.0% |
| Cost of Revenue | $6.9M | -39.0% |
| Gross Profit | $19.4M | -27.2% |
| R&D Expense | $3.0M | +7.5% |
| SG&A Expense | $14.4M | +1.2% |
| Operating Income | $2.0M | -79.3% |
| Pre-tax Income | $2.3M | -78.0% |
| Income Tax | $887K | -51.2% |
| Net Income | $1.4M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $18.0M | -4.3% |
| Accounts Receivable | $8.0M | -49.1% |
| Inventory | $14.6M | +17.6% |
| Current Assets | $44.5M | -9.2% |
| Total Assets | $65.5M | -6.0% |
| Current Liabilities | $9.6M | -38.8% |
| Long-term Debt | $7.8M | +5955.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.3M | -81.2% |
| Capital Expenditures | $1.8M | +63.6% |
| Investing Cash Flow | -$1.8M | -63.6% |
| Financing Cash Flow | -$221K | -17.3% |
| Free Cash Flow | -$588K | -110.6% |
| -83.8% |
| EPS (Basic) | $0.12 | -84.4% |
| EPS (Diluted) | $0.12 | -84.4% |
| Total Liabilities |
| $19.8M |
| -26.8% |
| Stockholders' Equity | $45.7M | +7.2% |